SCHEMBL4368090

SCHEMBL4368090

O=C(NSc1cccc(CCc2cccnc2)c1)NC(=O)c1cc2ccccc2o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
HPGD P15428 2/20 0.46
KDM4E B2RXH2 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
CHRNB2 P17787 4/20 0.45
CHRNA7 P36544 4/20 0.45
CHRNA4 P43681 4/20 0.45
KCNH2 Q12809 1/20 0.45
GFER P55789 1/20 0.44
NPC1 O15118 3/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TP53 P04637 1/20 0.42
PTK2B Q14289 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370773 0.92 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EL3MBTL1CHRNB2
SCHEMBL4366368 0.84 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EL3MBTL1CHRNB2
SCHEMBL3634482 0.83 SMN1; SMN2 (0.51) ALDH1A1HPGDNPC1LMNATSHR
SCHEMBL4366956 0.80 SMN1; SMN2 (0.48) ALDH1A1HPGDNPC1LMNATSHR
SCHEMBL4370668 0.79 SMN1; SMN2 (0.50) ALDH1A1HPGDKDM4ENPC1LMNA
SCHEMBL4368094 0.78 ALDH1A1 (0.77) ALDH1A1L3MBTL1CHRNB2CHRNA7CHRNA4
SCHEMBL4361546 0.77 HPGD (0.49) ALDH1A1HPGDL3MBTL1NPC1TSHR
SCHEMBL4375566 0.77 SMN1; SMN2 (0.49) ALDH1A1HPGDKDM4EL3MBTL1NPC1
SCHEMBL4360383 0.76 SMN1; SMN2 (0.47) ALDH1A1HPGDNPC1LMNATSHR
SCHEMBL4365533 0.74 NPC1 (0.47) ALDH1A1HPGDKDM4EL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US claimed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US claimed
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2004-07-15 US claimed
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-7094807-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-22 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138205-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, TPMT ALDH1A1 310/4885HPGD 3824/4885KDM4E 1098/4885
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 ALDH1A1 221/4885HPGD 3743/4885KDM4E 1559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.